Thomas Areschoug

2.1k total citations
22 papers, 1.7k citations indexed

About

Thomas Areschoug is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Infectious Diseases. According to data from OpenAlex, Thomas Areschoug has authored 22 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Public Health, Environmental and Occupational Health, 10 papers in Immunology and 7 papers in Infectious Diseases. Recurrent topics in Thomas Areschoug's work include Streptococcal Infections and Treatments (18 papers), Neonatal and Maternal Infections (16 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Thomas Areschoug is often cited by papers focused on Streptococcal Infections and Treatments (18 papers), Neonatal and Maternal Infections (16 papers) and Antimicrobial Resistance in Staphylococcus (7 papers). Thomas Areschoug collaborates with scholars based in Sweden, United Kingdom and United States. Thomas Areschoug's co-authors include Gunnar Lindahl, Siamon Gordon, Margaretha Stålhammar‐Carlemalm, Charlotte Larsson, Jenny M. Woof, Ajit Varki, Victor Nizet, Aaron F. Carlin, Richard J. Pleass and Ingrid Karlsson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Thomas Areschoug

22 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Areschoug Sweden 20 719 608 494 389 313 22 1.7k
Piet C. Aerts Netherlands 21 194 0.3× 475 0.8× 387 0.8× 476 1.2× 464 1.5× 39 1.4k
Jannet Katz United States 27 373 0.5× 900 1.5× 664 1.3× 252 0.6× 254 0.8× 46 2.2k
Jan Liese Germany 18 366 0.5× 760 1.3× 515 1.0× 341 0.9× 322 1.0× 31 1.9k
Hans B. Lomholt Denmark 23 268 0.4× 188 0.3× 301 0.6× 460 1.2× 184 0.6× 47 1.9k
Eva Rozdzinski Germany 18 367 0.5× 150 0.2× 325 0.7× 307 0.8× 396 1.3× 32 1.2k
Måns Ullberg Sweden 26 421 0.6× 497 0.8× 357 0.7× 626 1.6× 493 1.6× 60 2.0k
Sathit Pichyangkul Thailand 28 1.0k 1.4× 1.2k 2.0× 404 0.8× 403 1.0× 502 1.6× 62 2.4k
Vilasack Thammavongsa United States 11 180 0.3× 505 0.8× 679 1.4× 144 0.4× 651 2.1× 12 1.4k
Jutta M. Loeffler United States 18 181 0.3× 359 0.6× 640 1.3× 525 1.3× 245 0.8× 19 2.0k
Anne M. Berry Australia 23 636 0.9× 313 0.5× 467 0.9× 1.4k 3.6× 382 1.2× 28 2.2k

Countries citing papers authored by Thomas Areschoug

Since Specialization
Citations

This map shows the geographic impact of Thomas Areschoug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Areschoug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Areschoug more than expected).

Fields of papers citing papers by Thomas Areschoug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Areschoug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Areschoug. The network helps show where Thomas Areschoug may publish in the future.

Co-authorship network of co-authors of Thomas Areschoug

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Areschoug. A scholar is included among the top collaborators of Thomas Areschoug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Areschoug. Thomas Areschoug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ali, Syed R., Jerry J. Fong, Aaron F. Carlin, et al.. (2014). Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. The Journal of Experimental Medicine. 211(6). 1231–1242. 158 indexed citations
2.
Wu, Yongzheng, et al.. (2013). Secreted Group IIA Phospholipase A2 Protects Humans Against the Group B Streptococcus: Experimental and Clinical Evidence. The Journal of Infectious Diseases. 208(12). 2025–2035. 37 indexed citations
3.
Nordström, Therése, Anders I. Olin, Syed R. Ali, et al.. (2011). Human Siglec-5 Inhibitory Receptor and Immunoglobulin A (IgA) Have Separate Binding Sites in Streptococcal β Protein. Journal of Biological Chemistry. 286(39). 33981–33991. 24 indexed citations
4.
Wines, Bruce D., Halina M. Trist, William Farrugia, et al.. (2011). A Conserved Host and Pathogen Recognition Site on Immunoglobulins: Structural and Functional Aspects. Advances in experimental medicine and biology. 946. 87–112. 10 indexed citations
5.
Wu, Yongzheng, et al.. (2011). A Novel Bacterial Resistance Mechanism against Human Group IIA-Secreted Phospholipase A2: Role of Streptococcus pyogenes Sortase A. The Journal of Immunology. 187(12). 6437–6446. 20 indexed citations
6.
Carlin, Aaron F., Yung‐Chi Chang, Thomas Areschoug, et al.. (2009). Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. The Journal of Experimental Medicine. 206(8). 1691–1699. 134 indexed citations
7.
Areschoug, Thomas & Siamon Gordon. (2009). Scavenger receptors: role in innate immunity and microbial pathogenesis. Cellular Microbiology. 11(8). 1160–1169. 240 indexed citations
8.
Ghumra, Ashfaq, Jianguo Shi, Richard S. McIntosh, et al.. (2009). Structural requirements for the interaction of human IgM and IgA with the human Fcα/μ receptor. European Journal of Immunology. 39(4). 1147–1156. 38 indexed citations
9.
Areschoug, Thomas, et al.. (2008). Evasion of macrophage scavenger receptor A‐mediated recognition by pathogenic streptococci. European Journal of Immunology. 38(11). 3068–3079. 43 indexed citations
10.
Areschoug, Thomas & Siamon Gordon. (2008). Pattern Recognition Receptors and Their Role in Innate Immunity: Focus on Microbial Protein Ligands. PubMed. 15. 45–60. 102 indexed citations
11.
Stålhammar‐Carlemalm, Margaretha, et al.. (2007). Nonimmunodominant Regions Are Effective as Building Blocks in a Streptococcal Fusion Protein Vaccine. Cell Host & Microbe. 2(6). 427–434. 35 indexed citations
12.
Lindahl, Gunnar, Margaretha Stålhammar‐Carlemalm, & Thomas Areschoug. (2005). Surface Proteins ofStreptococcus agalactiaeand Related Proteins in Other Bacterial Pathogens. Clinical Microbiology Reviews. 18(1). 102–127. 288 indexed citations
13.
Areschoug, Thomas, et al.. (2005). The Streptococcal Blr and Slr Proteins Define a Family of Surface Proteins with Leucine-Rich Repeats: Camouflaging by Other Surface Structures. Journal of Bacteriology. 188(2). 378–388. 24 indexed citations
14.
Areschoug, Thomas, Fredric Carlsson, Margaretha Stålhammar‐Carlemalm, & Gunnar Lindahl. (2004). Host–pathogen interactions in Streptococcus pyogenes infections, with special reference to puerperal fever and a comment on vaccine development. Vaccine. 22. S9–S14. 35 indexed citations
15.
Areschoug, Thomas, Margaretha Stålhammar‐Carlemalm, Ingrid Karlsson, & Gunnar Lindahl. (2002). Streptococcal β Protein Has Separate Binding Sites for Human Factor H and IgA-Fc. Journal of Biological Chemistry. 277(15). 12642–12648. 82 indexed citations
16.
Areschoug, Thomas, Sara Linse, Margaretha Stålhammar‐Carlemalm, L O Hedén, & Gunnar Lindahl. (2002). A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface. Journal of Bacteriology. 184(22). 6376–6383. 19 indexed citations
17.
Pleass, Richard J., Thomas Areschoug, Gunnar Lindahl, & Jenny M. Woof. (2001). Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89. Journal of Biological Chemistry. 276(11). 8197–8204. 96 indexed citations
18.
Stålhammar‐Carlemalm, Margaretha, Thomas Areschoug, Charlotte Larsson, & Gunnar Lindahl. (2000). Cross‐Protection between Group A and Group B Streptococci Due to Cross‐Reacting Surface Proteins. The Journal of Infectious Diseases. 182(1). 142–149. 29 indexed citations
19.
Stålhammar‐Carlemalm, Margaretha, Thomas Areschoug, Charlotte Larsson, & Gunnar Lindahl. (1999). The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Molecular Microbiology. 33(1). 208–219. 127 indexed citations
20.
Johnsson, Eskil, Thomas Areschoug, Jiří Městecký, & Gunnar Lindahl. (1999). An IgA-binding Peptide Derived from a Streptococcal Surface Protein. Journal of Biological Chemistry. 274(21). 14521–14524. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026